Roberto Alfano

Roberto Alfano

Auto-generated profile, based on publicly available information

Roberto Alfano

Department of Anesthesiology, Surgery and Emergency University of Campania Luigi Vanvitelli Naples Italy

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2017 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
Aimilios LallasAimilios Lallas
Aimilios Lallas
ZAZoe Apalla
Zoe Apalla
DID. Ioannides
D. Ioannides
ELE. Lazaridou
E. Lazaridou
AKATHANASSIOS KYRGIDIS
ATHANASSIOS KYRGIDIS
PTPhilipp Tschandl
Philipp Tschandl

20 August 2018 in Current Oncology Reports
Verified
Journal Article
Closed access
PDF file
ADAnna Diana
Anna Diana
EFElisena Franzese
Elisena Franzese
SCSara Centonze
Sara Centonze
FCFrancesca Carlino
Francesca Carlino
CCCarminia Maria Della Corte
Carminia Maria Della Corte
MOMichele Orditura
Michele Orditura

28 March 2017 in Expert Opinion on Biological Therapy
Verified
Journal Article
Closed access
FMFederica Zito Marino
Federica Zito Marino
PAPaolo Antonio Ascierto
Paolo Antonio Ascierto
GRGiulio Rossi
Giulio Rossi
SSStefania Staibano
Stefania Staibano
MMMarco Montella
Marco Montella
RFRenato Franco
Renato Franco
Tumor-infiltrating lymphocytes (TILs) are frequently observed in several tumors, reflecting the dynamic process of '"cancer immunoediting"'. Prognostic and predictive values of TILs have been demonstrated in different cancers, proving their pivotal role in clinical outcome. In recent years, new therapies targeting immune checkpoint inhibitors, especially CTLA-4 and PD-1/PDL-1 pathways, have been introduced into clinical practice. In this context, TILs may even have a possible utility as a predictive biomarker for immunotherapy response. Areas covered: In this review, the authors summarize the most relevant knowledge related to TILs. This includes their prognostic and predictive significance in various types of tumour and the recent findings about their potential role in the cancer immunotherapy. Expert opinion: TILs evaluation could lead to a predictive biomarker for immunotherapy effectiveness in several cancer types. Furthermore, typing of TILs subpopulation could have clinical relevance in patient selection for treatment with immune checkpoint inhibitors. However further studies are still needed.

1 October 2018 in Dermatologic Clinics
Verified
Journal Article
Closed access
Vincenzo PiccoloVincenzo Piccolo
Vincenzo Piccolo
TRTeresa Russo
Teresa Russo
EMElvira Moscarella
Elvira Moscarella
GBGabriella Brancaccio
Gabriella Brancaccio
RARoberto Alfano
Roberto Alfano
GAGiuseppe Argenziano
Giuseppe Argenziano

1 August 2017 in Melanoma Research
Verified
Journal Article
Closed access
AKAthanassios Kyrgidis
Athanassios Kyrgidis
ALAimilios Lallas
Aimilios Lallas
EMElvira Moscarella
Elvira Moscarella
CLCaterina Longo
Caterina Longo
RARoberto Alfano
Roberto Alfano
Giuseppe ArgenzianoGiuseppe Argenziano
Giuseppe Argenziano
The literature has not been able to conclude whether pregnancy influences the prognosis of melanoma. The aim of this study was to explore the prognosis of melanoma diagnosed during pregnancy or post partum [pregnancy-associated melanoma (PAM)] compared with melanoma in female patients who were not pregnant. We systematically searched for studies of female patients with melanoma that reported outcomes related to survival. Fifteen eligible studies were found. Overall, PAM was associated with a 17% higher mortality compared with melanoma diagnosed in female patients who were not pregnant (hazard ratio=1.17, 95% confidence interval: 1.03–1.33, P=0.02). The heterogeneity associated with this test was moderate (P=0.07; I 2=38%). PAM was also associated with a 50% higher recurrence rate compared with melanoma not associated with pregnancy (hazard ratio=1.50, 95% confidence interval: 1.19–1.90, P<0.001). The heterogeneity associated with this test was low (P=0.69; I 2=0%). A limitation of this meta-analysis is the definition of PAM, which is not unanimous among the studies included. Our results indicate that PAM is associated with a worse prognosis than melanoma not related to pregnancy, both in terms of overall survival and disease-free survival. On the basis of our data, we anticipate that the survival difference we report here will be further amplified with the addition of future well-carried out studies. We suggest that detection of PAM requires particular awareness by healthcare professionals.

1 November 2018 in Journal of Diabetes and its Complications
Verified
Journal Article
Closed access
LSLinda Sommese
Linda Sommese
GBGiuditta Benincasa
Giuditta Benincasa
Michele LanzaMichele Lanza
Michele Lanza
ASAntonio Sorriento
Antonio Sorriento
CSConcetta Schiano
Concetta Schiano
CNClaudio Napoli
Claudio Napoli